[HTML][HTML] NF-κB inhibitors in treatment and prevention of lung cancer

RR Rasmi, KM Sakthivel… - Biomedicine & …, 2020 - Elsevier
Intracellular signalling pathways have provided excellent resource for drug development
particularly in the development of cancer therapeutics. A wide variety of malignancies …

[PDF][PDF] NF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy target

W Chen, Z Li, L Bai, Y Lin - Front Biosci (Landmark Ed), 2011 - article.imrpress.com
Introduction 3. NF-kappaB activation pathways 3.1. Protein components in the NF-kappaB
family 3.2. The pathways leading to NF-kappaB activation 4. NF-kappaB's cellular functions …

Statin therapy reduces growth of abdominal aortic aneurysms

W Karrowni, S Dughman, GP Hajj… - Journal of …, 2011 - journals.sagepub.com
Background The aim of this study was to evaluate the influence of statins on the growth of
small abdominal aortic aneurysms (AAAs). Methods We retrospectively examined AAA …

Pathophysiology of abdominal aortic aneurysm: Biomarkers and novel therapeutic targets

M Torres-Fonseca, M Galan, D Martinez-Lopez… - Clínica e Investigación …, 2019 - Elsevier
Abdominal aortic aneurysm (AAA) is a vascular pathology with a high rate of morbidity and
mortality and a prevalence that, in men over 65 years, can reach around 8%. In this disease …

Delta-tocotrienol inhibits non-small-cell lung cancer cell invasion via the inhibition of NF-κB, uPA activator, and MMP-9

LD Rajasinghe, RH Pindiprolu… - OncoTargets and …, 2018 - Taylor & Francis
Background Delta-tocotrienol (δT), an isomer of vitamin E, exhibits anticancer properties in
different cancer types including non-small-cell lung cancer (NSCLC). Yet, anti-invasive …

[HTML][HTML] Experimental models of abdominal aortic aneurysms

JC Tsui - The open cardiovascular medicine journal, 2010 - ncbi.nlm.nih.gov
Despite being a leading cause of death in the West, the pathophysiology of abdominal aortic
aneurysms (AAA) is still incompletely understood. Pharmacotherapy to reduce the growth of …

[HTML][HTML] NF-kappaB, a mediator for lung carcinogenesis and a target for lung cancer prevention and therapy

W Chen, Z Li, L Bai, Y Lin - Frontiers in bioscience: a journal and …, 2011 - ncbi.nlm.nih.gov
Lung cancer ranks as the first malignant tumor killer worldwide. Despite the knowledge that
carcinogens from tobacco smoke and the environment constitute the main causes of lung …

Nifedipine attenuation of abdominal aortic aneurysm in hypertensive and non-hypertensive mice: Mechanisms and implications

XN Miao, KL Siu, H Cai - Journal of molecular and cellular cardiology, 2015 - Elsevier
Rupture of abdominal aortic aneurysm (AAA) is a lethal event. No oral medicine has been
available to prevent or treat AAA. We have recently identified a novel mechanism of eNOS …

Suppression of experimental abdominal aortic aneurysm in a rat model by the phosphodiesterase 3 inhibitor cilostazol

Q Zhang, J Huang, R Xia, X Duan, Y Jiang… - Journal of Surgical …, 2011 - Elsevier
BACKGROUND: The present experiments sought to determine whether cilostazol, a
selective inhibitor of cyclic adenosine monophosphate (cAMP) phosphodiesterase 3 …

l-Type Calcium Channel Inhibitor Diltiazem Prevents Aneurysm Formation by Blood Pressure–Independent Anti-Inflammatory Effects

A Mieth, M Revermann, A Babelova, A Weigert… - …, 2013 - Am Heart Assoc
Formation of abdominal aortic aneurysms is a progressive inflammatory process that
involves infiltration and differentiation of monocytes in the vessel wall, proliferation and …